The Chemours Company (NYSE:CC) Given Average Rating of “Hold” by Brokerages

The Chemours Company (NYSE:CCGet Free Report) has received a consensus rating of “Hold” from the ten brokerages that are presently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $17.50.

Several analysts have commented on the company. Truist Financial cut their target price on Chemours from $21.00 to $18.00 and set a “buy” rating on the stock in a research note on Monday, November 10th. Royal Bank Of Canada dropped their price objective on Chemours from $19.00 to $17.00 and set an “outperform” rating on the stock in a research report on Monday, November 10th. Weiss Ratings reissued a “sell (d)” rating on shares of Chemours in a research report on Wednesday, October 8th. Zacks Research cut shares of Chemours from a “hold” rating to a “strong sell” rating in a research note on Friday, October 17th. Finally, UBS Group dropped their price target on shares of Chemours from $21.00 to $18.00 and set a “buy” rating on the stock in a report on Tuesday, November 11th.

Get Our Latest Research Report on Chemours

Chemours Stock Down 2.6%

NYSE:CC opened at $10.96 on Wednesday. The company has a debt-to-equity ratio of 13.66, a quick ratio of 0.88 and a current ratio of 1.71. The firm has a market cap of $1.64 billion, a P/E ratio of -4.94 and a beta of 1.64. Chemours has a fifty-two week low of $9.13 and a fifty-two week high of $22.38. The firm has a 50-day simple moving average of $14.38 and a two-hundred day simple moving average of $13.23.

Chemours (NYSE:CCGet Free Report) last posted its quarterly earnings results on Thursday, November 6th. The specialty chemicals company reported $0.20 EPS for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.04). The firm had revenue of $1.50 billion for the quarter, compared to analysts’ expectations of $1.50 billion. Chemours had a negative net margin of 5.70% and a positive return on equity of 35.27%. The company’s quarterly revenue was down .9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.40 EPS. Chemours has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. Analysts predict that Chemours will post 2.03 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Shareholders of record on Friday, November 14th will be paid a dividend of $0.0875 per share. The ex-dividend date is Friday, November 14th. This represents a $0.35 dividend on an annualized basis and a yield of 3.2%. Chemours’s payout ratio is currently -15.77%.

Institutional Trading of Chemours

Large investors have recently modified their holdings of the company. MTM Investment Management LLC bought a new position in Chemours in the second quarter valued at about $27,000. SouthState Corp bought a new stake in shares of Chemours during the 1st quarter valued at about $34,000. GAMMA Investing LLC increased its position in shares of Chemours by 130.7% during the 2nd quarter. GAMMA Investing LLC now owns 3,175 shares of the specialty chemicals company’s stock valued at $36,000 after purchasing an additional 1,799 shares during the last quarter. Evelyn Partners Asset Management Ltd bought a new position in shares of Chemours in the 2nd quarter worth approximately $37,000. Finally, Advisory Services Network LLC bought a new position in shares of Chemours in the 3rd quarter worth approximately $54,000. Institutional investors own 76.26% of the company’s stock.

Chemours Company Profile

(Get Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

See Also

Analyst Recommendations for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.